MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06−0.19 (-15.20%)
Close on Nov 18, 2026Market cap $6.98MP/E –Yield –
MetaVia net income
Net income is the profit left for shareholders after every expense, interest and tax.
MetaVia's net income for the twelve months ending Jun 30, 2026 was -$14.45M. For fiscal 2025 it was -$12.97M. The highest annual figure on record is -$320.00K in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.97M | – |
| FY2024 | Dec 31, 2024 | -$27.59M | – |
| FY2023 | Dec 31, 2023 | -$12.47M | – |
| FY2022 | Dec 31, 2022 | -$13.97M | – |
| FY2021 | Dec 31, 2021 | -$15.28M | – |
| FY2020 | Dec 31, 2020 | -$29.68M | – |
| FY2019 | Dec 31, 2019 | -$21.31M | – |
| FY2018 | Dec 31, 2018 | -$15.53M | – |
| FY2017 | Dec 31, 2017 | -$33.42M | – |
| FY2016 | Dec 31, 2016 | -$14.59M | – |
| FY2015 | Dec 31, 2015 | -$9.03M | – |
| FY2014 | Dec 31, 2014 | -$320.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.32M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.17M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.65M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.71M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.82M | – |
| Q2 FY2023 | Jun 30, 2023 | -$734.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.30M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.88M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.58M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.46M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.92M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.51M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.05M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.73M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.33M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.62M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.46M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.66M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.08M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.22M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.67M | – |
| Q2 FY2017 | Jun 30, 2017 | -$10.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.50M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.21M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.88M | – |
See a number that looks wrong?